Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ramkhamhaeng Hospital PCLBKK:RAM-R 73 Capex-to-Operating-Income is 2.07 as of Jun. 2026, which is 67% above its 10-year median of 1.24. GuruFocus rates BKK:RAM-R with a GF Score™ of 73/100 and a GF Value™ of ฿42.29. The stock has 6 warning signs investors should review. Among 346 Healthcare Providers & Services companies, Ramkhamhaeng Hospital PCL ranks worse than 83.53% on this metric.
Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.
Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.
Ramkhamhaeng Hospital PCL Capex-to-Operating-Income Related Terms
Ramkhamhaeng Hospital PCL Capex-to-Operating-Income Historical Data
* Premium members only.
The historical data trend for Ramkhamhaeng Hospital PCL's Capex-to-Operating-Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:RAM-R vs HCA, THC, EHC: Capex-to-Operating-Income Comparison
For the Medical Care Facilities subindustry, Ramkhamhaeng Hospital PCL's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ramkhamhaeng Hospital PCL Capex-to-Operating-Income vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ramkhamhaeng Hospital PCL's Capex-to-Operating-Income distribution charts can be found below:
* The bar in red indicates where Ramkhamhaeng Hospital PCL's Capex-to-Operating-Income falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Capex-to-Operating-Income of 2.07 mean?
Ramkhamhaeng Hospital PCL (BKK:RAM-R) has a Capex-to-Operating-Income of 2.07 as of Jun. 2026. Capex to Operating Income ratio measures a company's investments in physical assets to its operating income. View historical data on Ramkhamhaeng Hospital PCL and its competitors. This is 67% above median its historical median of 1.24. Over the past decade, Ramkhamhaeng Hospital PCL's Capex-to-Operating-Income has ranged from 0.21 to 4.41. According to the industry distribution chart, Ramkhamhaeng Hospital PCL ranks #289 out of 346 companies in the Healthcare Providers & Services industry, placing it in the top 83.5%.
Is Ramkhamhaeng Hospital PCL's Capex-to-Operating-Income too high?
Ramkhamhaeng Hospital PCL's current Capex-to-Operating-Income of 2.07 is 67% above median its 10-year median of 1.24. Over the past 10 years, this metric has ranged from a low of 0.21 to a high of 4.41. The Healthcare Providers & Services industry median Capex-to-Operating-Income is 0.52. Ramkhamhaeng Hospital PCL's value of 2.07 is 301.9% above this industry median. Based on the distribution chart, Ramkhamhaeng Hospital PCL ranks #289 out of 346 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Ramkhamhaeng Hospital PCL has a GF Score™ of 73/100, reflecting its overall financial health beyond just this single metric.
How does Ramkhamhaeng Hospital PCL's Capex-to-Operating-Income compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ramkhamhaeng Hospital PCL ranks #289 out of 346 companies for Capex-to-Operating-Income. This places Ramkhamhaeng Hospital PCL in the lower half of its industry. The industry median Capex-to-Operating-Income is 0.52. Ramkhamhaeng Hospital PCL's value of 2.07 is 301.9% above this benchmark. Historically, Ramkhamhaeng Hospital PCL's own Capex-to-Operating-Income has ranged from 0.21 to 4.41 over the past decade. While the company's 10-year median is 1.24 vs. the industry median of 0.52, Ramkhamhaeng Hospital PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Capex-to-Operating-Income for a Healthcare Providers & Services company?
The median Capex-to-Operating-Income among Healthcare Providers & Services companies is 0.52, based on 346 companies in the industry. Companies in the top quartile (top 25%) have a Capex-to-Operating-Income significantly above this median, while those in the bottom quartile fall well below. However, Capex-to-Operating-Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ramkhamhaeng Hospital PCL's current Capex-to-Operating-Income of 2.07 is 301.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Capex-to-Operating-Income mean?
A high Capex-to-Operating-Income can signal that a stock is expensive relative to its fundamentals. Capex to Operating Income ratio measures a company's investments in physical assets to its operating income. View historical data on Ramkhamhaeng Hospital PCL and its competitors. For the Healthcare Providers & Services industry, the median Capex-to-Operating-Income is 0.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ramkhamhaeng Hospital PCL's current Capex-to-Operating-Income is 2.07, which is 67% above median its own 10-year median of 1.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ramkhamhaeng Hospital PCL stock overvalued right now?
Ramkhamhaeng Hospital PCL (BKK:RAM-R) has a current Capex-to-Operating-Income of 2.07. The stock's GF Value™ is ฿42.29, compared to a current price of ฿17.40 — trading 58.9% below its estimated fair value. The current Capex-to-Operating-Income is 2.07, which is 67% above median its 10-year median of 1.24 and 301.9% above the Healthcare Providers & Services industry median of 0.52. Ramkhamhaeng Hospital PCL's overall GF Score™ is 73/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Capex-to-Operating-Income calculated?
Capex-to-Operating-Income is calculated from a company's financial statements. For Ramkhamhaeng Hospital PCL (BKK:RAM-R), the current Capex-to-Operating-Income is 2.07 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ramkhamhaeng Hospital PCL (BKK:RAM-R) Overvalued in 2026?
Based on GuruFocus' analysis, Ramkhamhaeng Hospital PCL stock appears to be undervalued.
The current stock price of ฿17.40 is trading 58.9% below its estimated GF Value™ of ฿42.29.
Key valuation signals for BKK:RAM-R:
Capex-to-Operating-Income: 2.07 (67% above median its 10-year median of 1.24)
GF Value™: ฿42.29 vs. price of ฿17.40 (58.9% below fair value)
Industry Position: 301.9% above the Healthcare Providers & Services median (#289 of 346)
No single metric tells the full story. See the BKK:RAM-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ramkhamhaeng Hospital PCL business activities are hospital and businesses that support medical care. The company provides medical treatment for all types of diseases by physicians and medical professionals in all specialties. Its medical services include the 24-hour Heart Center, RAM Pituitary Center for laparoscopic surgery for pituitary tumors, Neurology & Neurosurgery Center, and specialized medical centers such as Eye Clinic, Ear, Nose and Throat Clinic, Gastroenterology Clinic, Obstetrics and Gynecology Clinic, and Diabetes Clinic. The company operates through two segments: Hospital, which includes General Hospital and Hospital in Social Security and generates the maximum revenue; and Others, which includes sale of medical equipment and instruments. Its operations are in Thailand.
73GF Score
Get the complete analysis for BKK:RAM-R
Capex-to-Operating-Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:RAM-R has been successfully added to your 
